Technical Analysis for CORT - Corcept Therapeutics Incorporated

Grade Last Price % Change Price Change
grade A 17.18 0.53% 0.09
CORT closed up 0.53 percent on Thursday, July 2, 2020, on 77 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical CORT trend table...

Date Alert Name Type % Chg
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 3 Days in a Row Strength 0.53%
Calm After Storm Range Contraction 2.14%
Inside Day Range Contraction 2.14%
Calm After Storm Range Contraction 2.57%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.18%
Spinning Top Other 3.18%
Calm After Storm Range Contraction 3.18%
Narrow Range Bar Range Contraction 3.18%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also involved in an on-going Phase III study of mifepristone, the active ingredient in Korlym, for treatment of the psychotic features of psychotic depression. In addition, it discovers and develops three series of novel selective GR-II antagonists. The company has research and development agreements with Argenta Discovery Limited; Sygnature Discovery Limited; ICON Clinical Research, L.P.; and MedAvante, Inc. as well as has a patent license from Stanford University for developing mifepristone. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Pharmaceutical Organ Systems Surgery Disorders Endocrine System Hormones Diabetes Mellitus Depression Cushing's Syndrome Corcept Therapeutics Hyperglycemia Cortisol Endogenous Cushing's Syndrome

Is CORT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.52
52 Week Low 9.7
Average Volume 1,044,832
200-Day Moving Average 13.52
50-Day Moving Average 14.81
20-Day Moving Average 16.05
10-Day Moving Average 16.98
Average True Range 0.74
ADX 32.33
+DI 31.83
-DI 11.76
Chandelier Exit (Long, 3 ATRs ) 16.30
Chandelier Exit (Short, 3 ATRs ) 16.03
Upper Bollinger Band 18.17
Lower Bollinger Band 13.92
Percent B (%b) 0.77
BandWidth 26.49
MACD Line 0.70
MACD Signal Line 0.68
MACD Histogram 0.0218
Fundamentals Value
Market Cap 1.94 Billion
Num Shares 113 Million
EPS 0.20
Price-to-Earnings (P/E) Ratio 85.90
Price-to-Sales 19.04
Price-to-Book 31.30
PEG Ratio 0.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.16
Resistance 3 (R3) 18.15 17.82 17.99
Resistance 2 (R2) 17.82 17.57 17.82 17.94
Resistance 1 (R1) 17.50 17.42 17.34 17.51 17.88
Pivot Point 17.17 17.17 17.09 17.17 17.17
Support 1 (S1) 16.85 16.92 16.69 16.86 16.48
Support 2 (S2) 16.52 16.77 16.52 16.42
Support 3 (S3) 16.20 16.52 16.37
Support 4 (S4) 16.21